The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
CAR-T Meeting 2020 | CAR T-cell therapy: a field moving fast
John Gribben
• 30 Jan 2020
John Gribben, MD, DSc, FRCPath, FRCP, FMedSci, Barts Cancer Institute, London, UK, shares his highlights and discusses the importance of the 2nd European CAR T-Cell Meeting. Prof. Gribben highlights the progress observed in Europe in the last year, the use of CAR T-cells in solid tumors and gene editing. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
